Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (411-420 of 423) with videos related to

Pageof 43
Sort By:
Annals of Surgery|July 14, 2018
Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White PaperMichaela A West, Shelley Hwang, Ronald V Maier, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2025
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology GroupJacquelyn N Crane, David P Douglass, Sapna Oberoi, et al.
Toxins|September 27, 2024
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog ModelRose H Dicovitsky, Jill T Schappa, Ashley J Schulte, et al.
Frontiers in Medicine|August 29, 2025
Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSDDeLisa Fairweather, Katelyn A Bruno, Ashley A Darakjian, et al.
The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.
Cancer|June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trialsJonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Rheumatology Advances in Practice|December 11, 2024
Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersAshley A Darakjian, Mira Bhutani, DeLisa Fairweather, et al.
JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.
Cell Communication and Signaling : CCS|November 27, 2025
Donor-dependent heterogeneity in therapeutic effects of adipose tissue extracellular vesiclesDanielle J Beetler, Presley Giresi, Vivian Xu, et al.
Pageof 43

Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
Annals of Surgery|July 14, 2018
Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White PaperMichaela A West, Shelley Hwang, Ronald V Maier, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2025
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology GroupJacquelyn N Crane, David P Douglass, Sapna Oberoi, et al.
Toxins|September 27, 2024
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog ModelRose H Dicovitsky, Jill T Schappa, Ashley J Schulte, et al.
Frontiers in Medicine|August 29, 2025
Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSDDeLisa Fairweather, Katelyn A Bruno, Ashley A Darakjian, et al.
The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.
Cancer|June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trialsJonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Rheumatology Advances in Practice|December 11, 2024
Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersAshley A Darakjian, Mira Bhutani, DeLisa Fairweather, et al.
JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.
Cell Communication and Signaling : CCS|November 27, 2025
Donor-dependent heterogeneity in therapeutic effects of adipose tissue extracellular vesiclesDanielle J Beetler, Presley Giresi, Vivian Xu, et al.
Pageof 43